NAC Administration in Postoperative Liver Dysfunction

Indications for NAC Administration

The American Society of Anesthesiologists recommends NAC administration to postoperative patients with elevated liver enzymes and acute liver failure, regardless of acetaminophen involvement, as it improves transplant-free survival (64% vs 26%) and overall survival (76% vs 59%) 1, 2
In cases of suspected acetaminophen contribution to postoperative liver dysfunction, NAC should be considered due to its safety profile and potential benefit, although the evidence is not strong for routine prophylactic use in mild transaminase elevations 4, 3
For patients with severe hepatotoxicity (AST/ALT >1000 IU/L), immediate NAC administration and ICU-level care with early transplant hepatology consultation are required 3

The American College of Surgeons suggests assessing the severity of liver enzyme elevation, with AST/ALT >1000 IU/L or signs of acute liver failure (coagulopathy, encephalopathy) necessitating immediate NAC administration 1, 2, 3
Identifying the etiology of liver dysfunction is crucial, including checking acetaminophen levels, assessing for ischemic hepatitis, reviewing medications, and obtaining abdominal Doppler ultrasound to verify vessel patency (hepatic veins, portal vein) 1, 2

The American Association for the Study of Liver Diseases recommends NAC 150 mg/kg IV over 15 minutes, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours for acute liver failure (any cause), and the same protocol for acetaminophen-related liver dysfunction (any level with hepatotoxicity) 1, 2, 4, 3
NAC benefits are greatest in early coma stages (Grade I-II), and therapeutic acetaminophen levels do not exclude the potential benefit of NAC administration 1, 3, 5
Adverse effects of NAC are minimal, including nausea, vomiting, skin rash (<5%), or transient bronchospasm (1-2%), making it relatively safe to administer when benefit is possible 1